* Maravai LifeSciences Holdings Inc MRVI.OQ reported
quarterly
adjusted earnings of 1 cent per share for the quarter ended in
December, lower than the same quarter last year, when the
company reported EPS of 35 cents. The mean expectation of
eleven analysts for the quarter was for a loss of one cent per
share. Wall Street expected results to range from -2 cents
tozero cents per share.
* Revenue fell 63.8% to $74.14 million from a year ago;
analysts
expected $64.38 million.
* Maravai LifeSciences Holdings Inc's reported EPS for the
quarter
was a loss of 80 cents.
* The company reported a quarterly loss of $105.96 million.
* Maravai LifeSciences Holdings Inc shares had fallen
by 19.7%
this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 13.3%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $8.57
This summary was machine generated from LSEG data February 23 at
03:04 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.01 0.01 Beat
Sep. 30 2023 0.01 -0.01 Missed
Jun. 30 2023 0.01 0.00 Missed
Mar. 31 2023 0.04 0.03 Missed